| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |